Palliative MedicineNCT06110624
The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management
An observational study of Palliative Medicine, run by University Medical Center Groningen at 2 sites in Netherlands.
Trial summary
A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Palliative Medicine
- What is being tested?
- Survey
- How many people
- 70 participants
- Where
- 2 sitesNetherlands
- Study dates
- 18 Apr 2024to 28 Feb 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.
Who may be able to join
- Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:
- General practice
- Nursing home
- Hospital:
- Clinical geriatrics
- Medical oncology
Show all 9Show fewer
- Radiation oncology
- Pulmonology
- Cardiology
Who cannot join
- HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.
- GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.
Trial locations and contacts
2 sites in 1 country.
Netherlands2 sites
University Medical Center Groningen
Groningen
LUMC
Leiden
About this study
Official title: The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study
A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.
Read the detailed description
A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.
- Conditions
- Palliative Medicine
- Being tested
- Survey
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.
| Study group | Role | What they receive |
|---|---|---|
| Arm 1 | A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population. Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Questions evaluating Intention to Use (IU)
Questions evaluating Intention to Use (IU) (7-point Likert scales)
Measured: after 5 times use of the MuSt-PC tool within 3 months
Secondary outcomes (6)
Questions evaluating other modified TAM domains
Questions evaluating other modified TAM domains: Perceived Usefulness, Perceived Ease-of-Use, Attitude, Compatibility, Subjective norm, Facilitators, Habit (7-point Likert Scales).
Measured: after 5 times use of the MuSt-PC tool within 3 months
Perceived benefits and disadvantages of using MuSt-PC
Perceived benefits and disadvantages of using MuSt-PC (open-ended questions).
Measured: after 5 times use within 3 months
Suggestions to improve the MuSt-PC CDSS
Suggestions to improve the MuSt-PC CDSS (open-ended question).
Measured: after 5 times of the MuSt-PC tool within 3 months
An overview of the content of questions of participating GHCPs regarding MuSt-PC use.
An overview of the content of questions of participating GHCPs regarding MuSt-PC use. Questions will be analyzed qualitatively; coding will be done independently by two researchers. In case of disagreement, consensus will be achieved through discussion. Coding will result in categorization of question subject. Categorizations are ranked from most prevalent to least prevalent question subject (proportion of respondents).
Measured: after 5 times use within 3 months
Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.
Most useful elements of MuSt-PC will be evaluated with a multiple-choice question. (multiple answers allowed) Frequency and percentage of total respondents who chose the multiple choice answer possibilities will be evaluated
Measured: after 5 times use within 3 months
Mean scores of HCPs adherence to CDSS recommendations
Mean scores (5-point Likert scale) of HCPs adherence to CDSS recommendations (each time using MuSt-PC)
Measured: after 5 times use of the MuSt-PC tool within 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Oct 2023
- Study start18 Apr 2024
- Primary completion28 Feb 2025
- Study completion28 Feb 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Palliative MedicineStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Medical Center Groningen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- An KL Reyners, MD, PhD, Principal investigator, University Medical Center Groningen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06110624
- Sponsor's protocol ID
- 11265
- Status last verified
- Oct 2025
- First submitted
- 7 Oct 2023
- Last updated
- 25 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study
- ClinicalTrials.gov ID
- NCT06110624
- Acronym / sponsor ID
- 11265
- Conditions
- Palliative Medicine
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- University Medical Center GroningenUniversity, hospital or other
- Study start
- 18 Apr 2024 (actual)
- Primary completion
- 28 Feb 2025 (actual)
- Study completion
- 28 Feb 2025 (actual)
- First posted
- 31 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.
Detailed description
A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Arm 1 | – | Other: SurveyA targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.
Key inclusion criteria (9 listed)
- Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:
- General practice
- Nursing home
- Hospital:
Key exclusion criteria (2 listed)
- HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.
- GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyA survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice. | Other | Arm 1 |
Primary outcome
Questions evaluating Intention to Use (IU)
Time frame: after 5 times use of the MuSt-PC tool within 3 months
Questions evaluating Intention to Use (IU) (7-point Likert scales)
6 secondary outcomes
Questions evaluating other modified TAM domains
Time frame: after 5 times use of the MuSt-PC tool within 3 months
Perceived benefits and disadvantages of using MuSt-PC
Time frame: after 5 times use within 3 months
Suggestions to improve the MuSt-PC CDSS
Time frame: after 5 times of the MuSt-PC tool within 3 months
An overview of the content of questions of participating GHCPs regarding MuSt-PC use.
Time frame: after 5 times use within 3 months
Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.
Time frame: after 5 times use within 3 months
Mean scores of HCPs adherence to CDSS recommendations
Time frame: after 5 times use of the MuSt-PC tool within 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Nov 2025.
Related trials for Palliative Medicine
Not yet recruitingPhase 3
Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management
Cancer Pain, Cancer Palliative Care
RecruitingObservational study
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Neoplasm, Colorectal, Cognitive Impairment
RecruitingObservational study
Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
Lennox Gastaut Syndrome
Not yet recruiting
Primary Palliative Care - a Feasibility Cluster Trial
Palliative Care, Primary Palliative Care
RecruitingObservational study
Routine Evaluation of People Living With Cancer
Cachexia; Cancer, Advanced Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
An KL Reyners, MD, PhD principal investigator
University Medical Center Groningen
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Palliative Medicine, run by University Medical Center Groningen at 2 sites in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Questions evaluating Intention to Use (IU) (time frame: after 5 times use of the MuSt-PC tool within 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2025.